Wang-lin Qu, Xu-jun Zhang, Gao-ang Wang, Wei-xin Tian, Kang Chen, Yuan-yi Ye et al. Structure-based virtual screening with AlphaFold identifies CLIP1-LTK inhibitors. // Acta Pharmacologica Sinica. – 2026. – DOI: 10.1038/s41401-026-01957-9. – URL: https://www.nature.com/articles/s41401-026-01957-9
Wang-lin Qu, Xu-jun Zhang, Gao-ang Wang, Wei-xin Tian, Kang Chen, Yuan-yi Ye, Shi-cheng Chen, Ru-bi Hu, Yi-fei Liu, Chao Shen, Dan Li, Yu Kang, Sheng Tian, Peng Teng, Ting-jun Hou, & Pei-chen Pan (2026). Structure-based virtual screening with AlphaFold identifies CLIP1-LTK inhibitors. Acta Pharmacologica Sinica. https://doi.org/10.1038/s41401-026-01957-9
Wang-lin Qu, et al. “Structure-based virtual screening with AlphaFold identifies CLIP1-LTK inhibitors.” Acta Pharmacologica Sinica, 2026. doi:10.1038/s41401-026-01957-9.
@article{Qu2026,
title = {Structure-based virtual screening with AlphaFold identifies CLIP1-LTK inhibitors},
author = {Qu, Wang-lin and Zhang, Xu-jun and Wang, Gao-ang and Tian, Wei-xin and Chen, Kang and Ye, Yuan-yi and Chen, Shi-cheng and Hu, Ru-bi and Liu, Yi-fei and Shen, Chao and Li, Dan and Kang, Yu and Tian, Sheng and Teng, Peng and Hou, Ting-jun and Pan, Pei-chen},
journal = {Acta Pharmacologica Sinica},
year = {2026},
doi = {10.1038/s41401-026-01957-9},
url = {https://www.nature.com/articles/s41401-026-01957-9}
}
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01958-8 Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than...
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/s41573-026-01583-4 From hope to adoption: an industry perspective on the maturation of new approach methodologies